The Efficacy of Anti-VEGF Therapy for Putative or Visible CNV in Central Serous Chorioretinopathy by Optical Coherence Tomography Angiography

Figure 4

The outcome of both eyes in the same patient after anti-VEGF treatment. (a–c) The right eye. Visible CNV with peripheral anastomosis and dense microvasculature visualized in the choriocapillaris layer on OCTA before (a) and after (b) anti-VEGF treatment, showing vascular remodeling after anti-VEGF treatment. (c) OCTA b-scan showed the resolution of SRF and irregular pigment epithelial detachment (PED) before and after anti-VEGF treatment. (d–f) The left eye. Nonhomogenous hyperreflectivity (putative CNV) in the choriocapillaris layer on OCTA before (d) and after (e) anti-VEGF treatment, showing complete regression of putative CNV after treatment; (f) OCTA b-scan showed complete resolution of SRF after anti-VEGF treatment.

(a)

(b)

(c)

(d)

(e)

(f)